AUA Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-100
Closed -$54K 373
2022
Q2
$54K Sell
100
-55
-35% -$30.3K 0.03% 139
2022
Q1
$92K Hold
155
0.05% 122
2021
Q4
$103K Buy
155
+75
+94% +$46.8K 0.06% 112
2021
Q3
$46K Hold
80
0.03% 131
2021
Q2
$40K Hold
80
0.02% 135
2021
Q1
$37K Hold
80
0.02% 136
2020
Q4
$37K Hold
80
0.03% 135
2020
Q3
$35K Buy
80
+25
+45% +$10.3K 0.03% 132
2020
Q2
$20K Sell
55
-25
-31% -$8.38K 0.02% 122
2020
Q1
$23K Hold
80
0.02% 128
2019
Q4
$26K Hold
80
0.02% 130
2019
Q3
$23K Hold
80
0.02% 134
2019
Q2
$23K Hold
80
0.02% 134
2019
Q1
$22K Hold
80
0.02% 135
2018
Q4
$18K Sell
80
-45
-36% -$10.6K 0.02% 140
2018
Q3
$30K Hold
125
0.02% 132
2018
Q2
$26K Hold
125
0.02% 134
2018
Q1
$26K Buy
125
+25
+25% +$5.25K 0.02% 138
2017
Q4
$19K Hold
100
0.02% 150
2017
Q3
$19K Hold
100
0.02% 148
2017
Q2
$17K Hold
100
0.02% 151
2017
Q1
$15K Hold
100
0.02% 139
2016
Q4
$14K Buy
+100
New +$14.7K 0.01% 144

Other funds holding TMO

AUA Capital Management's TMO Position: Q3 2022 in Review

AUA Capital Management sold out of Thermo Fisher Scientific (TMO) in Q3 2022, closing a stake of 100 shares — an estimated $54K sold.

AUA Capital Management first reported a position in TMO in Q4 2016 and held it in 23 quarters. The position peaked at $103K in Q4 2021. 2,266 funds tracked by Wall St. Rank hold TMO as of Q3 2022.

  • AUA Capital Management reported no remaining Thermo Fisher Scientific position as of Q3 2022 after selling out during the quarter.
  • AUA Capital Management sold 100 Thermo Fisher Scientific shares in Q3 2022, an estimated $54K.
  • AUA Capital Management first reported a position in Thermo Fisher Scientific in Q4 2016 and held it in 23 quarters.
  • AUA Capital Management's Thermo Fisher Scientific position peaked at $103K in Q4 2021.
  • 2,266 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2022.

Based on AUA Capital Management's 13F filing for Q3 2022, filed 9 Nov 2022.